Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind study
Titel:
Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind study
Auteur:
Dimopoulos, Meletios Siegel, David S Lonial, Sagar Qi, Junyuan Hajek, Roman Facon, Thierry Rosinol, Laura Williams, Catherine Blacklock, Hilary Goldschmidt, Hartmut Hungria, Vania Spencer, Andrew Palumbo, Antonio Graef, Thorsten Eid, Joseph E Houp, Jennifer Sun, Linda Vuocolo, Scott Anderson, Kenneth C